Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-24

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for the generic combination drug Amlodipine and Olmesartan Medoxomil, manufactured by Macleods Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)